Browsing Over 119 Sessions

Legend
  • Break (8) (8)
  • Industry Symposia  (3) (3)
  • Welcome Remarks, President Address, Award Presentation (1) (1)
  • Honorary Lecture (1) (1)
  • Local Entertainment (1) (1)
  • Networking Reception in Exhibit Hall (1) (1)
  • Asthma Sesion (3) (3)
  • Critical Care Session (3) (3)
  • COPD Session (6) (6)
  • Lung Cancer Sesion (4) (4)
  • Sleep Session (1) (1)
  • Infections Session (2) (2)
  • Procedures/Simulations (4) (4)
  • ILD Session (2) (2)
  • Physiology Session (1) (1)
  • Cardiology Session (1) (1)
  • Misc .Session (4) (4)
Hall 1
Hall 2
Hall 3
Hall 4
Hall 5
Exhibition
  • 10:00 AM
  • 11:00 AM
  • 12:00 PM
  • 01:00 PM
  • 02:00 PM
  • 03:00 PM
  • 04:00 PM
  • 05:00 PM
  • 06:00 PM
  • 07:00 PM
  • 08:00 PM
  • Session Time
    10:00 AM - 10:30 AM
    Session Type
    Asthma Sesion
    Session Description
    Description:Management of mild asthma has been for a long time unsatisfactory and not tested in clinical trials. The use (overuse) of SABA in patients "treated as" mild asthmatics has become of concern, and the association with severe adverse events has become clear. Adherence to regular ICS treatment is a major issue in this population. The rationale and efficacy of the “as needed ICS” will be discussed in this session.Learning Objectives:Review concerns associated with the use of rescue SABA in the absence of maintenance treatment.Discuss merits of as-needed ICS treatment strategies in mild asthma.
  • Session Time
    10:35 AM - 11:05 AM
    Session Type
    Misc .Session
  • Session Time
    11:10 AM - 11:40 AM
    Session Type
    Lung Cancer Sesion
    Session Description
    Description:During this session, we will review the evidence of benefit and harms from lung cancer screening and discuss how implementation could impact this balance. We will highlight some practical issues in establishing a lung cancer screening program.Learning Objectives:Describe the benefits and harms of low-dose CT scan-based lung cancer screening. Discuss the implementation of a high-quality lung cancer screening program.
  • Session Time
    11:45 AM - 12:15 PM
    Session Type
    ILD Session
    Session Description
    Description:The epidemiology and natural history of cystic fibrosis (CF) is changing. In most western countries, the predicted median survival increased, over the past 5 decades, from less than 12 to more than 45 years with an estimated increase of the number of adult patients in the next decade of about 75%. Adults with CF major complications, from life-threatening respiratory infections to respiratory failure, lung transplantation and end-of-life management. New challenges include microbiology with a very high prevalence of multidrug-resistant pathogens, the use of CFTR modulators, including the role of these drugs in transplanted patients, and age-related complications (diabetes, osteoporosis, cancer, cardiovascular events). Considerable expertise is required to ensure all patients receive a high standard of care, with optimized drug and physical treatments and appropriate and holistic integration and management of the care of CF disease in other organ systems. These challenges generate new training needs and require renewed efforts in education and training to recruit and retain the next generation of CF specialists.Learning Objectives: Improve the knowledge of advances in care delivery and on the use of new antibiotics, mucoactive drugs, correctors, and potentiators in the treatment of adult CF patients.
  • Session Time
    01:45 PM - 02:15 PM
    Session Type
    Asthma Sesion
    Session Description
    Description:Asthma affects older adults to the same extent as children and adolescents. However, one is led to imagine that asthma prevalence decreases with aging and becomes a rare entity in the elderly. From a clinical perspective, this misconception has not trivial consequences in that, the recognition of the disease is delayed and the treatment postponed. The overall management of asthma in the elderly populations is also complicated by specific features that the disease develops in the most advanced ages and by the difficulties that the physician encounters when approaching the older asthmatic subjects. Asthma in older-age patients presents with specific clinical presentations and may encounter gaps and pitfalls in the diagnostic and therapeutic approaches. A multidisciplinary and multidimensional management of asthma in the elderly is, therefore, strongly advocated.
  • Session Time
    02:20 PM - 03:25 PM
    Session Type
    Asthma Sesion
    Session Description
    Description:This session will focus on currently available clinical, functional, and biological tools that can be used to characterize the various phenotypes and endotypes of asthma, with special regard to severe asthma.Learning Objectives: Learning objectives include a comprehensive evaluation of asthmatic patients in order to properly personalize both standard and biological therapies, especially with regard to severe asthma.
  • Session Time
    04:10 PM - 05:40 PM
    Session Type
    Lung Cancer Sesion
    Session Description
    Learning Objectives:Review interesting complicated cases of lung cancer with an expert panel, including pulmonology, thoracic surgery, and interventional pulmonary medicine. Better understand, through case-based scenarios, how decisions are made with regards to the diagnosis, staging, and treatment of lung cancer.
  • Session Time
    05:45 PM - 06:15 PM
    Session Type
    Welcome Remarks, President Address, Award Presentation
  • Session Time
    06:15 PM - 06:45 PM
    Session Type
    Honorary Lecture
    Session Description
    Description:For many years, it has been maintained that COPD is a disease caused by tobacco smoking and characterized by accelerated decline of lung function (FEV1) with time. However, it has also been demonstrated that between 20% and 40% of patients with COPD are not smokers and that many of them do not show evidence of an enhanced FEV1 decline during their life. It has also been established that some patients never achieve normal peak lung function in adulthood and that some patients with COPD have a normal rate of FEV1 decline. These different “trajectories,” recently described in patients with COPD, arise the question of whether COPD is actually a unique disease or a “syndrome” and whether the so-called “natural history” of COPD is always the same in all patients affected by the disease. In any case, depending on the “traitable traits” that can be identified in each patient, several different therapeutic approaches should be considered, “tailoring” the treatment according to the criteria of the “precision medicine.”
  • Session Time
    06:45 PM - 07:15 PM
    Session Type
    Local Entertainment
  • Session Time
    07:15 PM - 08:15 PM
    Session Type
    Networking Reception in Exhibit Hall
  • Session Time
    10:00 AM - 10:30 AM
    Session Type
    COPD Session
    Session Description
    Description:Based on the seminal observations of Fletcher and Peto, modification of the accelerated decline in FEV1was considered the holy grail in initial clinical trials in COPD. Based on the concept of offering anti-inflammatory therapy, exacerbations and mortality were introduced as outcomes in large intervention studies. These studies have contributed to a tunnel perspective on COPD and a one size fits all approach to a complex heterogeneous syndrome.Learning Objectives:A one size fits all approach is killing for profound understanding of underlying mechanisms of a disease condition. A personalized management strategy starts by understanding the heterogeneity of the COPD syndrome.
  • Session Time
    10:35 AM - 11:05 AM
    Session Type
    COPD Session
    Session Description
    Description:Many patients with moderate to advanced COPD of the emphysema phenotype develop resting and dynamic hyperinflation. Hyperinflation results in the need to increase intrathoracic pressures to maintain ventilation. Whether due to decreased venous return or increased cardiac impedance, the result is a decrease in cardiac output. Recent studies show that pharmacologic and nonpharmacologic interventions aimed at reducing hyperinflation have benefits on cardiac function in patients with COPD and significant hyperinflation.Learning Objectives:Provide the basic pathophysiologic changes seen in patients with COPD and emphysema-induced lung hyperinflation. Describe the known effect of these changes on cardiac function.Provide the evidence that shows that pharmacologic and non-pharmacologic interventions improve resting and dynamic hyperinflation with beneficial effects on cardiac function.
  • Session Time
    11:10 AM - 11:40 AM
    Session Type
    COPD Session
    Session Description
    Description:Oxidative stress can be an important mechanism of "amplification" in COPD, which is further increased during exacerbations. Oxidants are generated mainly in nonphysiologic conditions by both cigarette smoke and other particulates inhaled and released by activated inflammatory cells, such as macrophages and neutrophils. Mucoregulatory drugs can both reduce the generation of ROS and neutralize oxidants, with the potential to indirectly influence inflammation in COPD and consequently have an impact on symptoms, as well as reduce exacerbations.
  • Session Time
    11:45 AM - 12:15 PM
    Session Type
    Physiology Session
    Session Description
    Description:It is altogether appropriate that we acknowledge the founders of the field of pulmonary rehabilitation, a highly effective therapy for patients with chronic lung disease. This lecture will review the evolution of pulmonary rehabilitation as its physiologic basis was elucidated. Recent developments will also be reviewed and linked to their historical context.Learning Objectives: Recognize the early innovators who defied the common conception that exercise was to be avoided in dyspneic patients with chronic respiratory disease.Review how the physiologic benefits of rehabilitative exercise programs were established.Consider the implications of the growing scarcity of in-center rehabilitation programs.
  • Session Time
    12:30 PM - 01:30 PM
    Session Title
    Session Type
    Industry Symposia
  • Session Time
    01:45 PM - 02:15 PM
    Session Type
    Sleep Session
    Session Description
    Description:Obesity hypoventilation syndrome is a relatively common cause of chronic hypercapnic respiratory failure and can occur with or without obstructive sleep apnea, yet the optimal approach to treatment is not well defined. This will be a case-based interactive session that will review current diagnostic criteria, recent literature and guidelines and various management strategies. During this session, the faculty and attendees will also review the role of CPAP and more advanced nocturnal ventilatory modalities on outcomes in patients with OHS.Learning Objectives:Define obesity hypoventilation syndrome (OHS) and diagnostic approaches.Understand the most recent literature and guidelines related to the management of OHS.List different management strategies, including the use of various nocturnal ventilatory modes, that may improve outcomes in this patient population.
  • Session Time
    02:20 PM - 02:50 PM
    Session Type
    Misc .Session
    Session Description
    Description:A great variability in end-of-life practice is observed in the terminally ill mainly because physicians are not always able to correctly predict survival. There is a need for a clear discussion about decision making earlier than when acute respiratory failure ensues, especially in patients with chronic respiratory diseases. Indeed, a perceived poor quality of life does not necessarily correlate with a clear willingness to refuse invasive or noninvasive mechanical ventilation. The overall incidence of end-of-life practices in Europe is only partially known, but there are important differences between countries or regions, reflecting the absence of a common strategy even within the European community. Concerning the problem of patients affected by chronic pulmonary disorders, it was shown that only 13% of units provide information to patients with severe COPD when they are stable, and 25% of patients with oxygen dependence have discussed care with medical staff.Learning Objectives:Describe the terminology of end-of-life decision (E-o-L).Illustrate the different approach in different geographic locations (ie, EU vs US and within the EU).Discuss the potential timing to start speaking about E-o-L.Explore tricks and tips to improve patient/clinician communication about E-o-L issues.
  • Session Time
    02:55 PM - 03:25 PM
    Session Title
    Session Type
    COPD Session
    Session Description
    Description:The lecture will review the latest evidence regarding endoscopic lung volume reduction and provide the most updated information about different devices available. Attendees will be able to improve candidate selection in order to maximize benefits. Learning Objectives: Update the knowledge of the audience about BLVR approaches. Provide precise information to improve patient selection, which is the key factor for better outcomes.
  • Session Time
    04:10 PM - 05:40 PM
    Session Type
    Infections Session
    Session Description
    Description:The emergence of antibacterial resistance is one of the main causes that prevents the reduction of mortality and the general burden of pneumonia. Multidrug-resistant bacteria (MDR) are frequently the cause of hospital-acquired pneumonia but could be the cause of community-acquired pneumonia in subjects with specific risk factors or conditions, such as altered lung structure (eg, bronchiectasis), antibiotic selective pressure, and general conditions, such as chronic renal failure and liver cirrhosis reduce the physical and immune defense favoring the selection and the emergence of MDR. New molecules and alternative ways of administration are constantly being researched to find new methods to better manage pneumonia. Development of new molecules or new combination regimens are very important for patients with severe infections and in specific subgroups of patients. The development of new antibiotics with new targets could allow the overcome of the actual bacterial resistance. Moreover, it could be useful to evaluate and study different antibiotic combinations in order to reduce the future development of new bacterial-resistant strains. Research on new antibiotics and antiviral drugs must be continued to find new drugs able to overcome the progressive development of resistant strains. Prevention of difficult-to treat-infections and the development of methods to increase host immunodeficiencies could be new efficient strategies to fight infections and reduce the appearance of resistance strains.Learning Objectives: Improve the knowledge on advances in care delivery and on the use of new antibiotics, vaccinations, and other measures to prevent pneumonia.
  • Session Time
    10:00 AM - 10:30 AM
    Session Type
    Cardiology Session
    Session Description
    Description:This session will review current prognostic scoring systems that can be utilized to more specifically inform the appropriate setting for treatment of acute pulmonary embolism.Learning Objectives:Recall validated prognostic scores in patients with acute PESelect appropriate patients for outpatient therapy of PE.Identify patients with PE most appropriate for ICU care.
  • Session Time
    10:35 AM - 11:05 AM
    Session Type
    Critical Care Session
    Session Description
    Description:The use of extracorporeal membrane oxygenation for severe respiratory failure has been increasing exponentially since the influenza epidemics of 2009/2010. The identification of patients most likely to benefit is a crucial step, as well as the timing of ECMO initiation. In this session, patient selection, severity assessment, benefits of ECMO, and timing will be discussed, based on guidelines and most recent clinical trials.
  • Session Time
    11:10 AM - 11:40 AM
    Session Type
    Infections Session
    Session Description
    Description:This session will provide an overview of tuberculosis epidemiology across the globe along with recent advances and insight into prevention, diagnosis and treatment.
  • Session Time
    11:45 AM - 12:15 PM
    Session Type
    Misc .Session
    Session Description
    Learning Objectives: Discuss various techniques utilized to effectively report and disseminate research findings. Review factors that contribute to success in the reporting of research results, outcomes, and learning. Outline practical steps to help ensure your research is appreciated.
  • Session Time
    12:30 PM - 01:30 PM
    Session Title
    Session Type
    Industry Symposia
  • Session Time
    01:45 PM - 02:15 PM
    Session Type
    Critical Care Session
    Session Description
    Description:Pharmacotherapy for ARDS has been tested in preclinical and clinical studies. However, to date, no pharmacologic interventions have proven effective. Personalized medicine targeting the different ARDS phenotypes has emerged as an option to improve survival.Learning Objectives: ARDS pathophysiology and the main pharmacologic agents that may counteract certain pathophysiologic features will be discussed. Furthermore, the importance of personalized medicine in improving the therapeutic approach to ARDS will be addressed.
  • Session Time
    02:20 PM - 02:50 PM
    Session Type
    Lung Cancer Sesion
    Session Description
    Learning Objectives: Be able to provide a differential diagnosis of treatment-related complications of lung cancer. Utilize cases to illustrate different complications of lung cancer treatment and how to manage them. Review immunotherapy-induced pneumonitis recognition and treatment.
  • Session Time
    02:55 PM - 03:25 PM
    Session Type
    Lung Cancer Sesion
    Session Description
    Learning objectives:Understand indication to screening and selection of high risk individuals. Learn risks and benefits of LC screening. Understand the diagnostic algorithm to reduce false-positive cases. Learn stage distribution of screening cancers and indication to lung-sparing minimally invasive surgery.
  • Session Time
    04:10 PM - 05:40 PM
    Session Title
    Session Type
    COPD Session
  • Session Time
    10:00 AM - 11:05 AM
    Session Type
    Procedures/Simulations
    Session Description
    Description:This session will review the indications, contraindications, outcomes, and potential adverse events related to fundamental bronchoscopic techniques.Learning Objectives:List the safety issues and techniques of bronchoscopy in special populations: pregnancy, severe asthma, COPD, OSA, and heart disease.Enumerate four techniques for managing massive airway bleeding.Mention the expected results and complications from BAL, brushings, and endobronchial and transbronchial biopsy.Fundamentals of Bronchoscopy Hands-on SimulationParticipants will learn new skills in this hands-on course led by experts in bronchoscopy from Italy and USA. Course content will cover managing massive hemoptysis, foreign body extraction, airway and mediastinal anatomy and cryodebulking. After participating in this educational activity, the participants should be able to:• Outline and demonstrate the various techniques for managing massive airway bleeding• Demonstrate foreign body removal using flexible bronchoscopic techniques: forceps, basket, and cryoprobe• Define the role and demonstrate the use of endobronchial blockers for massive hemoptysis• Demonstrate equipment, setup, and techniques for performing cryodebulking bronchoscopy• Improve cognitive and technical skills pertinent to airway and mediastinal anatomy
  • Session Time
    11:10 AM - 11:40 AM
    Session Title
    Session Type
    Misc .Session
    Session Description
    Description:In 2017, more than 4,000 lung transplant procedures were reported to the International Society for Heart and Lung Transplantation.Learning Objectives: Discuss current activity and outcomes following lung transplantation. Define indications for lung transplantation. Review guidelines for LT candidate selection. Understand management of the lung transplant recipient. Review complications following lung transplantation. Discuss the immunosuppressive and other medications used in lung transplantation.
  • Session Time
    11:45 AM - 12:15 PM
    Session Type
    ILD Session
    Session Description
    Description:The session will begin with a rapid pictorial review, including radiologic images, challenging the audience to decide if sarcoidosis or not. Best practices in personalized medicine for our sarcoid patients and new advances in management to include "third-line" therapies will be presented.
  • Session Time
    12:30 PM - 01:30 PM
    Session Type
    Industry Symposia
    Session Description
    During this session, we will discuss key elements of reach design and manuscript preparation that help to improve the chances that your manuscript will be published and impact clinical care. Learning Objectives: Discuss elements of research design that impact the fidelity and importance of your research findings. Discuss the preparation of a high-quality manuscript. Provide general tips on what makes a medical manuscript attractive to reviewers. Introduce a systematic approach to each aspect of the manuscript process, including the abstract, introduction, methods, results, and discussion. Learn how to utilize your tables and figures to maximal effect. Review of the submission and review process from the journals perspective.
  • Session Time
    01:45 PM - 03:25 PM
    Session Title
    Session Type
    COPD Session
    Session Description
    Description:COPD represents one of the commonest noncommunicable diseases with a prevalence that is continuously increasing and is one of the major causes of chronic morbidity and mortality worldwide that bears a major social and economic burden on health-care systems. To understand the pathophysiologic modifications is essential and fundamental in order to better understand COPD, as this is the first point for every clinician. So, the COPD clinical presentation is related to morphologic, functional, and clinical characteristics, in terms of symptoms, exacerbations, and biological parameters. All these topics must be known and evaluated for good clinical management.Learning Objectives:Understand the lung pathophysiologic modifications from early to severe stage in patients with COPD.Discuss the symptoms variability and their clinical relevance.Explain the clinical presentation of COPD exacerbations and their differences.Describe the importance of biological parameters with particular attention to the blood eosinophils.
  • Session Time
    04:10 PM - 05:40 PM
    Session Title
    Session Type
    Critical Care Session